Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Śląski W Katowicach, Dk Chem Organic Synthesis Ltd Spółka KomandytowafiledCriticalUniwersytet Śląski W Katowicach
Priority to PL420629ApriorityCriticalpatent/PL232831B1/en
Publication of PL420629A1publicationCriticalpatent/PL420629A1/en
Publication of PL232831B1publicationCriticalpatent/PL232831B1/en
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Przedmiotem zgłoszenia jest nowa pochodna karbaminianów, która charakteryzuje się tym, że ma strukturę chemiczną według wzoru 1, gdzie R1 stanowi grupę metylową, R2 - grupę metylową, R3 - grupę metylową, fenylową lub benzylową. Przedmiotem zgłoszenia jest też zastosowanie nowych pochodnych karbaminianów do wytwarzania substancji czynnych przeznaczonych do leczenia choroby Alzheimera.The subject of the application is a new derivative of carbamates, which is characterized in that it has a chemical structure according to formula 1, where R1 is a methyl group, R2 is a methyl group, R3 is a methyl, phenyl or benzyl group. The subject of the application is also the use of new carbamate derivatives for the production of active substances intended for the treatment of Alzheimer's disease.
PL420629A2017-02-232017-02-23New derivatives of carbamates and their application
PL232831B1
(en)
Compound n- (2- (6-fluoro-1-h-indol-3-yl) ethyl) -3- (2,2,3,3-tetrafluoropropoxy) benzylamine or its salt, 5-ht6 receptor antagonist; pharmaceutical composition; Use in the treatment of Alzheimer's disease.
pharmaceutical compositions suitable for oral administration and parenteral administration, methods for preventing or treating fungal infection in a human or animal individual and for producing a pharmaceutical composition, and use of a pharmaceutical composition.